Especial | 29th International Congress on Thrombosis

<i class="iconlock fa fa-lock fa-1x" aria-hidden="true" style="color:#e82d43;"></i> Treatment options of immune and congenital thrombotic thrombocytopenic purpura

Treatment options of immune and congenital thrombotic thrombocytopenic purpura

Marijo Vodanović

<i class="iconlock fa fa-lock fa-1x" aria-hidden="true" style="color:#e82d43;"></i> Prevenção e tratamento do tromboembolismo venoso

Prevenção e tratamento do tromboembolismo venoso

Trombose. Um problema de saúde “potencialmente prevenível” na maioria dos casos

Trombose. Um problema de saúde “potencialmente prevenível” na maioria dos casos

<i class="iconlock fa fa-lock fa-1x" aria-hidden="true" style="color:#e82d43;"></i> Cancer-Associated Thrombosis and Immune Checkpoint Inhibitors: Update

Cancer-Associated Thrombosis and Immune Checkpoint Inhibitors: Update

Miguel Barbosa

<i class="iconlock fa fa-lock fa-1x" aria-hidden="true" style="color:#e82d43;"></i> Pediatric Venous Thromboembolism: Why and When?

Pediatric Venous Thromboembolism: Why and When?

Teresa Seara Sevivas

<i class="iconlock fa fa-lock fa-1x" aria-hidden="true" style="color:#e82d43;"></i> Modern Treatment of Pulmonary Embolism in High-Risk Patients

Modern Treatment of Pulmonary Embolism in High-Risk Patients

Rita Calé

Com o apoio: